FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225518587> ?p ?o ?g. }

• W4225518587 abstract "Abstract Background COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. Methods We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period. Results Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78–3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05–1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00–1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1–6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0–1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1–1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. Conclusions Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas." @default.
• W4225518587 created "2022-05-05" @default.
• W4225518587 creator A5003818933 @default.
• W4225518587 creator A5005779461 @default.
• W4225518587 creator A5006633004 @default.
• W4225518587 creator A5009978154 @default.
• W4225518587 creator A5011023321 @default.
• W4225518587 creator A5012186253 @default.
• W4225518587 creator A5012199457 @default.
• W4225518587 creator A5012572735 @default.
• W4225518587 creator A5016974789 @default.
• W4225518587 creator A5028156447 @default.
• W4225518587 creator A5032262582 @default.
• W4225518587 creator A5032298939 @default.
• W4225518587 creator A5051619491 @default.
• W4225518587 creator A5054391046 @default.
• W4225518587 creator A5056116775 @default.
• W4225518587 creator A5060569928 @default.
• W4225518587 creator A5063231876 @default.
• W4225518587 creator A5065031002 @default.
• W4225518587 creator A5066846892 @default.
• W4225518587 creator A5067830871 @default.
• W4225518587 creator A5070676485 @default.
• W4225518587 creator A5070763071 @default.
• W4225518587 creator A5071781411 @default.
• W4225518587 creator A5071815350 @default.
• W4225518587 creator A5074394409 @default.
• W4225518587 creator A5074515020 @default.
• W4225518587 creator A5074902538 @default.
• W4225518587 creator A5078618702 @default.
• W4225518587 creator A5079178548 @default.
• W4225518587 creator A5079405214 @default.
• W4225518587 creator A5079979177 @default.
• W4225518587 creator A5080978434 @default.
• W4225518587 creator A5082182829 @default.
• W4225518587 creator A5086897371 @default.
• W4225518587 creator A5090564143 @default.
• W4225518587 date "2022-02-10" @default.
• W4225518587 modified "2023-10-09" @default.
• W4225518587 title "Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark" @default.
• W4225518587 cites W2093274439 @default.
• W4225518587 cites W2944434778 @default.
• W4225518587 cites W3015940872 @default.
• W4225518587 cites W3031193631 @default.
• W4225518587 cites W3035189381 @default.
• W4225518587 cites W3037177566 @default.
• W4225518587 cites W3045382531 @default.
• W4225518587 cites W3046353798 @default.
• W4225518587 cites W3084059074 @default.
• W4225518587 cites W3089400139 @default.
• W4225518587 cites W3094416776 @default.
• W4225518587 cites W3094968263 @default.
• W4225518587 cites W3105546145 @default.
• W4225518587 cites W3124903095 @default.
• W4225518587 cites W3128017291 @default.
• W4225518587 cites W3128674638 @default.
• W4225518587 cites W3130202594 @default.
• W4225518587 cites W3133738744 @default.
• W4225518587 cites W3145455230 @default.
• W4225518587 cites W3193653705 @default.
• W4225518587 cites W3194807182 @default.
• W4225518587 cites W4220772901 @default.
• W4225518587 doi "https://doi.org/10.1186/s12879-022-07102-1" @default.
• W4225518587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35144550" @default.
• W4225518587 hasPublicationYear "2022" @default.
• W4225518587 type Work @default.
• W4225518587 citedByCount "9" @default.
• W4225518587 countsByYear W42255185872021 @default.
• W4225518587 countsByYear W42255185872022 @default.
• W4225518587 countsByYear W42255185872023 @default.
• W4225518587 crossrefType "journal-article" @default.
• W4225518587 hasAuthorship W4225518587A5003818933 @default.
• W4225518587 hasAuthorship W4225518587A5005779461 @default.
• W4225518587 hasAuthorship W4225518587A5006633004 @default.
• W4225518587 hasAuthorship W4225518587A5009978154 @default.
• W4225518587 hasAuthorship W4225518587A5011023321 @default.
• W4225518587 hasAuthorship W4225518587A5012186253 @default.
• W4225518587 hasAuthorship W4225518587A5012199457 @default.
• W4225518587 hasAuthorship W4225518587A5012572735 @default.
• W4225518587 hasAuthorship W4225518587A5016974789 @default.
• W4225518587 hasAuthorship W4225518587A5028156447 @default.
• W4225518587 hasAuthorship W4225518587A5032262582 @default.
• W4225518587 hasAuthorship W4225518587A5032298939 @default.
• W4225518587 hasAuthorship W4225518587A5051619491 @default.
• W4225518587 hasAuthorship W4225518587A5054391046 @default.
• W4225518587 hasAuthorship W4225518587A5056116775 @default.
• W4225518587 hasAuthorship W4225518587A5060569928 @default.
• W4225518587 hasAuthorship W4225518587A5063231876 @default.
• W4225518587 hasAuthorship W4225518587A5065031002 @default.
• W4225518587 hasAuthorship W4225518587A5066846892 @default.
• W4225518587 hasAuthorship W4225518587A5067830871 @default.
• W4225518587 hasAuthorship W4225518587A5070676485 @default.
• W4225518587 hasAuthorship W4225518587A5070763071 @default.
• W4225518587 hasAuthorship W4225518587A5071781411 @default.
• W4225518587 hasAuthorship W4225518587A5071815350 @default.
• W4225518587 hasAuthorship W4225518587A5074394409 @default.
• W4225518587 hasAuthorship W4225518587A5074515020 @default.
• W4225518587 hasAuthorship W4225518587A5074902538 @default.
• W4225518587 hasAuthorship W4225518587A5078618702 @default.
• W4225518587 hasAuthorship W4225518587A5079178548 @default.

• next